1、 KIM R D,CHUNG V,ALESE O B,et al.A phase 2 multi-institutional study of nivolumab for patients with advanced refractory biliary tract cancer[J].JAMA Oncol,2020,6(6):888-894. KIM R D,CHUNG V,ALESE O B,et al.A phase 2 multi-institutional study of nivolumab for patients with advanced refractory biliary tract cancer[J].JAMA Oncol,2020,6(6):888-894.
2、 ABOU-ALFA G K,MACARULLA T,JAVLE M M,et al.Ivosidenib in IDH1-mutant,chemotherapy-refractory cholangiocarcinoma(ClarIDHy):a multicentre,randomised,double-blind,placebo-controlled,phase 3 study[J].Lancet Oncol,2020,21(6):796-807. ABOU-ALFA G K,MACARULLA T,JAVLE M M,et al.Ivosidenib in IDH1-mutant,chemotherapy-refractory cholangiocarcinoma(ClarIDHy):a multicentre,randomised,double-blind,placebo-controlled,phase 3 study[J].Lancet Oncol,2020,21(6):796-807.
3、 LAMARCA A,BARRIUSO J,MCNAMARA M G,et al.Molecular targeted therapies:Ready for “prime time”in biliary tract cancer[J].J Hepatol,2020,73(1):170-185. LAMARCA A,BARRIUSO J,MCNAMARA M G,et al.Molecular targeted therapies:Ready for “prime time”in biliary tract cancer[J].J Hepatol,2020,73(1):170-185.
4、 CERCEK A,BOERNER T,TAN B R,et al.Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma:A phase 2 clinical trial[J].JAMA Oncol,2020,6(1):60-67. CERCEK A,BOERNER T,TAN B R,et al.Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma:A phase 2 clinical trial[J].JAMA Oncol,2020,6(1):60-67.
5、 LV T R,HU H J,LIU F,et al.The effect of trans arterial chemoembolization in the management of intrahepatic cholangiocarcinoma.A systematic review and meta-analysis[J]. Eur J Surg Oncol,2022,48(5):956-966. LV T R,HU H J,LIU F,et al.The effect of trans arterial chemoembolization in the management of intrahepatic cholangiocarcinoma.A systematic review and meta-analysis[J]. Eur J Surg Oncol,2022,48(5):956-966.
6、 BRANDI G,RIZZO A,DALL’OLIO F G,et al.Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma:a retrospective single-center experience[J].Int J Hyperthermia,2020,37(1):479-485. BRANDI G,RIZZO A,DALL’OLIO F G,et al.Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma:a retrospective single-center experience[J].Int J Hyperthermia,2020,37(1):479-485.
7、 GIORGIO A,CALISTI G,de STEFANO G,et al.Radiofrequency ablation for intrahepatic cholangiocarcinoma:retrospective analysis of a single centre experience[J].Anticancer Res,2011,31(12):4575-4580. GIORGIO A,CALISTI G,de STEFANO G,et al.Radiofrequency ablation for intrahepatic cholangiocarcinoma:retrospective analysis of a single centre experience[J].Anticancer Res,2011,31(12):4575-4580.
8、 LI Q,CHEN C,SU J,et al.Recurrence and prognosis in intrahepatic cholangiocarcinoma patients with different etiology after radical resection:a multi-institutional study[J]. BMC Cancer,2022,22(1):329. LI Q,CHEN C,SU J,et al.Recurrence and prognosis in intrahepatic cholangiocarcinoma patients with different etiology after radical resection:a multi-institutional study[J]. BMC Cancer,2022,22(1):329.
9、 LUVIRA V,SATITKARNMANEE E,PUGKHEM A,et al.Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma[J]. Cochrane Database Syst Rev,2021,9(9):CD012814. LUVIRA V,SATITKARNMANEE E,PUGKHEM A,et al.Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma[J]. Cochrane Database Syst Rev,2021,9(9):CD012814.
10、 MORIZANE C,OKUSAKA T,MIZUSAWA J,et al.Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer:the FUGA-BT(JCOG1113)randomized phase III clinical trial[J].Ann Oncol,2019,30(12):1950-1958. MORIZANE C,OKUSAKA T,MIZUSAWA J,et al.Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer:the FUGA-BT(JCOG1113)randomized phase III clinical trial[J].Ann Oncol,2019,30(12):1950-1958.
11、 LAMARCA A,PALMER D H,WASAN H S,et al.Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer(ABC-06):a phase 3,open-label,randomised,controlled trial[J].Lancet Oncol,2021,22(5):690-701. LAMARCA A,PALMER D H,WASAN H S,et al.Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer(ABC-06):a phase 3,open-label,randomised,controlled trial[J].Lancet Oncol,2021,22(5):690-701.
12、 BUETTNER S,KOERKAMP B G,EJAZ A,et al.The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis[J].J Surg Oncol,2017,115(3):312-318. BUETTNER S,KOERKAMP B G,EJAZ A,et al.The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis[J].J Surg Oncol,2017,115(3):312-318.
13、 ITO T,BUTLER J R,NOGUCHI D,et al.A 3-decade,single-center experience of liver transplantation for cholangiocarcinoma:Impact of era,tumor size,location,and neoadjuvant therapy[J].Liver Transpl,2022,28(3):386-396. ITO T,BUTLER J R,NOGUCHI D,et al.A 3-decade,single-center experience of liver transplantation for cholangiocarcinoma:Impact of era,tumor size,location,and neoadjuvant therapy[J].Liver Transpl,2022,28(3):386-396.
14、 LUNSFORD K E,JAVLE M,HEYNE K,et al.Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy:A prospective case-series[J].Lancet Gastroenterol Hepatol,2018,3(5):337-348. LUNSFORD K E,JAVLE M,HEYNE K,et al.Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy:A prospective case-series[J].Lancet Gastroenterol Hepatol,2018,3(5):337-348.
15、 SAPISOCHIN G,JAVLE M,LERUT J,et al.Liver transplantation for cholangiocarcinoma and mixed hepatocellular cholangiocarcinoma:Working Group Report From the ILTS Transplant Oncology Consensus Conference[J].Transplantation,2020,104(6):1125-1130. SAPISOCHIN G,JAVLE M,LERUT J,et al.Liver transplantation for cholangiocarcinoma and mixed hepatocellular cholangiocarcinoma:Working Group Report From the ILTS Transplant Oncology Consensus Conference[J].Transplantation,2020,104(6):1125-1130.
16、 KITANO Y,YAMASHITA Y I,NAKAGAWA S,et al.Effectiveness of surgery for recurrent cholangiocarcinoma:A single center experience and brief literature review[J].Am J Surg,2020,219(1):175-180. KITANO Y,YAMASHITA Y I,NAKAGAWA S,et al.Effectiveness of surgery for recurrent cholangiocarcinoma:A single center experience and brief literature review[J].Am J Surg,2020,219(1):175-180.
17、 BENSON A B,D’ANGELICA M I,ABBOTT D E,et al.Guidelines Insights:Hepatobiliary Cancers,Version 2.2019[J].J Natl Compr Canc Netw,2019,17(4):302-310. BENSON A B,D’ANGELICA M I,ABBOTT D E,et al.Guidelines Insights:Hepatobiliary Cancers,Version 2.2019[J].J Natl Compr Canc Netw,2019,17(4):302-310.
18、 KANG C M,SUH K S,YI N J,et al.Should lymph nodes be retrieved in patients with intrahepatic cholangiocarcinoma?A collaborative Korea-Japan study[J].Cancers(Basel),2021,13(3):445. KANG C M,SUH K S,YI N J,et al.Should lymph nodes be retrieved in patients with intrahepatic cholangiocarcinoma?A collaborative Korea-Japan study[J].Cancers(Basel),2021,13(3):445.
19、 REGMI P,HU H J,PAUDYAL P,et al.Is laparoscopic liver resection safe for intrahepatic cholangiocarcinoma?A meta-analysis[J].Eur J Surg Oncol,2021,47(5):979-989. REGMI P,HU H J,PAUDYAL P,et al.Is laparoscopic liver resection safe for intrahepatic cholangiocarcinoma?A meta-analysis[J].Eur J Surg Oncol,2021,47(5):979-989.
20、 GUERRINI G P, ESPOSITO G, TARANTINO G, et al.Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma:the first meta-analysis[J].Langenbecks Arch Surg,2020,405(3):265-275. GUERRINI G P, ESPOSITO G, TARANTINO G, et al.Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma:the first meta-analysis[J].Langenbecks Arch Surg,2020,405(3):265-275.
21、 WANG W Q,LI J,LIANG B Y,et al.Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma:A propensity score matched study[J]. Front Oncol,2022(12):980736. WANG W Q,LI J,LIANG B Y,et al.Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma:A propensity score matched study[J]. Front Oncol,2022(12):980736.
22、 SI A,LI J,YANG Z,et al.Impact of anatomical versus non-anatomical liver resection on short- and long-term outcomes for patients with intrahepatic cholangiocarcinoma[J].Ann Surg Oncol,2019,26(6):1841-1850. SI A,LI J,YANG Z,et al.Impact of anatomical versus non-anatomical liver resection on short- and long-term outcomes for patients with intrahepatic cholangiocarcinoma[J].Ann Surg Oncol,2019,26(6):1841-1850.
23、 WANG L J,YAN X L,LI J,et al.Indocyanine green clearance test for the preoperative assessment of chemotherapy-related hepatic injury in patients with colorectal liver metastasis[J].Cancer Manag Res,2020(12):3237-3245. WANG L J,YAN X L,LI J,et al.Indocyanine green clearance test for the preoperative assessment of chemotherapy-related hepatic injury in patients with colorectal liver metastasis[J].Cancer Manag Res,2020(12):3237-3245.
24、 ZHANG X F,XUE F,HE J,et al.Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma[J].HPB(Oxford),2021,23(9):1456-1466. ZHANG X F,XUE F,HE J,et al.Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma[J].HPB(Oxford),2021,23(9):1456-1466.
25、 ZHANG Y,ZHANG Y,ZHU J,et al.Clinical application of indocyanine green fluorescence imaging in laparoscopic lymph node dissection for intrahepatic cholangiocarcinoma:A pilot study(with video)[J].Surgery,2022,171(6):1589-1595. ZHANG Y,ZHANG Y,ZHU J,et al.Clinical application of indocyanine green fluorescence imaging in laparoscopic lymph node dissection for intrahepatic cholangiocarcinoma:A pilot study(with video)[J].Surgery,2022,171(6):1589-1595.
26、 GUNIGANTI P,KIERANS A S.PET/MRI of the hepatobiliary system:review of techniques and applications[J].Clin Imaging,2021(71):160-169. GUNIGANTI P,KIERANS A S.PET/MRI of the hepatobiliary system:review of techniques and applications[J].Clin Imaging,2021(71):160-169.
27、 FIZ F,MASCI C,COSTA G,et al.PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival[J].Eur J Nucl Med Mol Imaging,2022,49(10):3387-3400. FIZ F,MASCI C,COSTA G,et al.PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival[J].Eur J Nucl Med Mol Imaging,2022,49(10):3387-3400.
28、 LIU G J,WANG W,LU M D,et al.Contrast-enhanced ultrasound for the characterization of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.Liver Cancer.2015 Dec;4(4):241-252. LIU G J,WANG W,LU M D,et al.Contrast-enhanced ultrasound for the characterization of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.Liver Cancer.2015 Dec;4(4):241-252.
29、 LI Q,CHE F,WEI Y,et al.Role of noninvasive imaging in the evaluation of intrahepatic cholangiocarcinoma:from diagnosis and prognosis to treatment response[J].Expert Rev Gastroenterol Hepatol,2021,15(11):1267-1279. LI Q,CHE F,WEI Y,et al.Role of noninvasive imaging in the evaluation of intrahepatic cholangiocarcinoma:from diagnosis and prognosis to treatment response[J].Expert Rev Gastroenterol Hepatol,2021,15(11):1267-1279.
30、 JIA X,LU S,ZENG Z,et al.Characterization of gut microbiota,bile acid metabolism,and cytokines in intrahepatic cholangiocarcinoma[J].Hepatology,2020,71(3):893-906. JIA X,LU S,ZENG Z,et al.Characterization of gut microbiota,bile acid metabolism,and cytokines in intrahepatic cholangiocarcinoma[J].Hepatology,2020,71(3):893-906.
31、 CLEMENTS O,ELIAHOO J,KIM J U,et al.Risk factors for intrahepatic and extrahepatic cholangiocarcinoma:A systematic review and meta-analysis[J].J Hepatol,2020,72(1):95-103. CLEMENTS O,ELIAHOO J,KIM J U,et al.Risk factors for intrahepatic and extrahepatic cholangiocarcinoma:A systematic review and meta-analysis[J].J Hepatol,2020,72(1):95-103.
32、 GAO Z,WANG J,SHEN S,et al.The impact of preoperative biliary drainage on postoperative outcomes in patients with malignant obstructive jaundice:A retrospective analysis of 290 consecutive cases at a single medical center[J]. World J Surg Oncol,2022,20(1):7. GAO Z,WANG J,SHEN S,et al.The impact of preoperative biliary drainage on postoperative outcomes in patients with malignant obstructive jaundice:A retrospective analysis of 290 consecutive cases at a single medical center[J]. World J Surg Oncol,2022,20(1):7.
33、 FLORIO A A,FERLAY J,ZNAOR A,et al.Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012[J].Cancer,2020,126(11):2666-2678. FLORIO A A,FERLAY J,ZNAOR A,et al.Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012[J].Cancer,2020,126(11):2666-2678.
